Diabetic kidneys can safely expand the donor pool

Transplantation

Volumn 74, Issue 1, 2002, Pages 141-145

  Becker, Yolanda T ^a   Leverson, Glen E ^a   D'Alessandro, Anthony M ^a   Sollinger, Hans W ^a   Becker, Bryan N ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGED; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; DONOR; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; RECIPIENT; REVIEW; TREATMENT OUTCOME;

EID: 0037099353     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200207150-00027     Document Type: Review

References (13)

1. Reduction of organ-retrieval damage and organ-discard rates
2. Kidney damage during organ retrieval: Data from UK National Transplant Database
3. How can we increase the number of organ and tissue donors?
4. Marginal donors: A viable solution for organ shortage
5. High-risk donors: Diabetics, the elderly, and others
6. Successful use of kidneys from diabetic cadaver kidney donors: 67- and 44-month graft survival
7. Reversal of lesions of diabetic nephropathy after pancreas transplantation
8. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes
9. Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients
10. Impact of renal cadaveric transplantation on survival in end-stage renal failure: Evidence for reduced mortality risk compared with hemodialysis during long-term follow-up
11. Using renal transplantation to evaluate a simple approach for predicting the impact of end-stage renal disease therapies on patient survival: Observe/expected lifespan
12. Differences in quality of life across renal replacement therapies: A meta-analytic comparison